Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2008 Mar 2;44:161–202. doi: 10.1016/S0065-3527(08)60329-2

Rotaviruses: Immunological Determinants of Protection Against Infection and Disease

Paul A Offit 1
PMCID: PMC7130874  PMID: 7817873

Publisher Summary

This chapter focuses on four important questions that remain unanswered: (1) what is the importance of virus serotype in formulating an optimal vaccine? (2) which immunological effector arm most likely protects against rotavirus disease? (3) by what means is virus antigen best presented to the host to elicit a protective immune response? (4) what are the advantages and disadvantages of replicating agents as compared to nonreplicating agents as candidate rotavirus vaccines? Although two proteins (vp4 and vp7) are probably important in inducing protection against challenge, it has not been clearly demonstrated that inclusion of the epidemiologically important human P or G type is important in protection against human disease. No immunological effector arm clearly explains protection against heterotypic challenge. Protection against disease is not predicted by rotavirus-specific neutralizing antibodies in serum. Oral inoculation may not be necessary to induce a protective, virus-specific immune response at the intestinal mucosal surface, but parenteral inoculation of experimental animals with rotavirus induces an immune response at the intestinal mucosal surface that is protective against challenge. Induction of a rotavirus-specific protective immune response is probably associated with the presence of virus-specific T and B cells in intestinal lymphoid tissues and virus-specific sIgA or IgG at the intestinal mucosal surface. There is some experimental evidence to support the hypothesis that neither rotavirus replication nor presentation of rotavirus antigen to the intestinal mucosal surface is necessary to achieve this aim.

References

  1. Adams W., Kraft L. Electron microscopic study of the intestinal epithelium of mice infected with the agent of epizootic diarrhea of infant mice (EDIM virus). Am. J. Pathol. 1967;51:39–44. [PMC free article] [PubMed] [Google Scholar]
  2. Ahmed M., Urasawa S., Taniguchi K., Urasawa T., Kobayashi N., Wakasugi F., Islam A., Sahikh H. Analysis of human rotavirus strains prevailing in Bangladesh in relation to nationwide floods brought by the 1988 monsoon. J. Clin. Microbiol. 1991;29:2273–2279. doi: 10.1128/jcm.29.10.2273-2279.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aiyar J., Ban M., Bhandari N., Kumar R., Raj P., Sazawal S. Rotavirus-specific antibody response in saliva of infants with rotavirus diarrhea. J. Infect. Dis. 1990;162:1383–1384. doi: 10.1093/infdis/162.6.1383. [DOI] [PubMed] [Google Scholar]
  4. Anderson E., Belshe R., Bartram J., Crookshanks-Newman F., Chanock R., Kapikian A. Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children. J. Infect. Dis. 1986;153:823–839. doi: 10.1093/infdis/153.5.823. [DOI] [PubMed] [Google Scholar]
  5. Andrew M., Boyle D., Whitfeld P., Lockett L., Anthony I., Bellamy A., Both G. The immunogenicity of vp7, a rotavirus antigen resident in the endoplasmic reticulum, is enhanced by cell surface expression. J. Virol. 1990;64:4776–4783. doi: 10.1128/jvi.64.10.4776-4783.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Andrew M., Boyle D., Coupar B., Reddy D., Bellamy A., Both G. Vacciniarotavirus vp7 recombinants protect mice against rotavirus-induced diarrhoea. Vaccine. 1992;10:185–191. doi: 10.1016/0264-410x(92)90010-h. [DOI] [PubMed] [Google Scholar]
  7. Banfield W., Kasnic G., Blackwell J. Further observations on the virus of epizootic diarrhea of infant mice: An electron microscopic study. Virology. 1968;36:411–421. doi: 10.1016/0042-6822(68)90166-9. [DOI] [PubMed] [Google Scholar]
  8. Barnes G., Hewson P., McLellan J., Doyle L., Knoches A., Kitchen W., Bishop R. A randomized trial of oral gammaglobulin in low-birth-weight infants infected with rotavirus. Lancet. 1982;i:1371–1373. doi: 10.1016/s0140-6736(82)92496-5. [DOI] [PubMed] [Google Scholar]
  9. Bell L., Clark H., Offit P., Slight P., Arbeter A., Plotkin S. Rotavirus serotype-specific neutralizing activity in human milk. Am. J. Dis. Child. 1988;142:275–278. [PubMed] [Google Scholar]
  10. Bellamy A., Both G. Molecular biology of rotaviruses. Adv. Virus Res. 1990;38:1–43. doi: 10.1016/s0065-3527(08)60858-1. [DOI] [PubMed] [Google Scholar]
  11. Bernstein D., Sander D., Smith V., Schiff G., Ward R. Protection from rotavirus reinfection: 2-year prospective study. J. Infect. Dis. 1990;164:277–283. doi: 10.1093/infdis/164.2.277. [DOI] [PubMed] [Google Scholar]
  12. Bernsteín D., Smith V., Sander D., Pax K., Schiff G., Ward R. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J. Infect. Dis. 1990;162:1055–1062. doi: 10.1093/infdis/162.5.1055. [DOI] [PubMed] [Google Scholar]
  13. Bingnan F., Unicomb L., Rahim Z., Banu N., Podder G., Clemens J., Van Loon F., Rao M., Malek A., Tzipori S. Rotavirus-associated diarrhea in rural Bangladesh: Two-year study of incidence and serotype distribution. J. Clin. Microbiol. 1991;29:1359–1363. doi: 10.1128/jcm.29.7.1359-1363.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Bishop R., Davidson G., Holmes I., Ruck B. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet. 1973;ii:1281–1283. doi: 10.1016/s0140-6736(73)92867-5. [DOI] [PubMed] [Google Scholar]
  15. Bishop R., Barnes G., Cipriani E., Lund J. Clinical immunity after neonatal rotavirus infection: A prospective longitudinal study in young children. N. Engl. J. Med. 1983;309:72–76. doi: 10.1056/NEJM198307143090203. [DOI] [PubMed] [Google Scholar]
  16. Bishop R., Lund J., Cipriani E., Unicomb L., Barnes G. Clinical, serological and intestinal immune responses to rotavirus infections in humans. In: de la Maza L., Peterson E., editors. Plenum; New York: 1990. pp. 85–110. (Medical Virology). [Google Scholar]
  17. Bishop R., Unicomb L., Barnes G. Epidemiology of rotavirus serotypes in Melbourne, Australia, from 1973 to 1989. J. Clin. Microbiol. 1991;29:862–868. doi: 10.1128/jcm.29.5.862-868.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Black R., Greenberg H., Kapikian A., Brown K., Becker S. Acquisition of serum antibody to Norwalk virus and rotavirus in relation to diarrhea in a longitudinal study of young children in rural Bangladesh. J. Infect. Dis. 1982;145:483–489. doi: 10.1093/infdis/145.4.483. [DOI] [PubMed] [Google Scholar]
  19. Blake P., Ramos S., MacDonald K., Rassi V., Gomes A., Ivey C., Bean N., Trabulsi L. Pathogen-specific risk factors and protective factors for acute diarrheal disease in urban Brazilian infants. J. Infect. Dis. 1993;167:627–632. doi: 10.1093/infdis/167.3.627. [DOI] [PubMed] [Google Scholar]
  20. Bohl E., Theil K., Saif L. Isolation and serotyping of porcine rotaviruses and antigenic comparison with other rotaviruses. J. Clin. Microbiol. 1984;19:105–111. doi: 10.1128/jcm.19.2.105-111.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Both G., Lockett L., Janardhana V., Edwards S., Bellamy A., Graham F., Prevec L., Andrew M. Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus vp7sc. Virology. 1993;193:940–950. doi: 10.1006/viro.1993.1203. [DOI] [PubMed] [Google Scholar]
  22. Both G., Bellamy A., Mitchell D. Rotavirus protein structure and function. Curr. Top. Microbiol. Immunol. 1994 doi: 10.1007/978-3-642-78256-5_4. in press. [DOI] [PubMed] [Google Scholar]
  23. Bridger J., Oldham G. A virulent rotavirus infections protect calves from disease with and without inducing high levels of neutralizing antibodies. J. Gen. Virol. 1987;68:2311–2317. doi: 10.1099/0022-1317-68-9-2311. [DOI] [PubMed] [Google Scholar]
  24. Bridger J., Oldham G., Howard C., Parsons K. In vivo depletion of CD8+ but not CD4+ or BOWC1+ lymphocytes increases primary rotavirus excretion in calves. Int. Symp. Double-Stranded RNA Viruses, 4th, Scottsdale, Ariz. Abstr. 1992:S6–S7. [Google Scholar]
  25. Brussow H., Offit P., Gerna G., Bruttin A., Sidoti J. Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus. J. Virol. 1990;64:4130–4136. doi: 10.1128/jvi.64.9.4130-4136.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Buller C., Moxley R. Natural infection of porcine ileal dome M cells with rotavirus and enteric adenovirus. Vet. Pathol. 1988;25:516–517. doi: 10.1177/030098588802500616. [DOI] [PubMed] [Google Scholar]
  27. Burns J.V., Krishnaney P.A., Greenberg H. Characterization of murine rotaviruses using the mouse model of rotavirus infection. Int. Symp. Double-Stranded RNA Viruses, 4th, Scottsdale, Ariz. Abstr. 1992:S5–S9. [Google Scholar]
  28. Cerf-Bensussan N., Guy-Grand D., Griscelli C. Intraepithelial lymphocytes of the human gut: Isolation, characterization and study of natural killer activity. Gut. 1985;26:81–88. doi: 10.1136/gut.26.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Chen D., Estes M., Ramig R. Specific interactions between rotavirus outer capsid proteins vp4 and vp7 determine expression of a cross-reactive, neutralizing vp4-specific epitope. J. Virol. 1992;66:432–439. doi: 10.1128/jvi.66.1.432-439.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Chiba S., Nakata S., Urasawa T., Urasawa S., Yokoyama T., Morita Y., Taniguchi K., Nakao T. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet. 1986;i:417–421. doi: 10.1016/s0140-6736(86)92133-1. [DOI] [PubMed] [Google Scholar]
  31. Christy C., Madore P., Pichichero M., Gala C., Pincus P., Vosefski D., Hoshino Y., Kapikian A., Dolin R. Field trials of rhesus rotavirus vaccine in infants. Pediatr. Infect. Dis. J. 1988;7:645–650. doi: 10.1097/00006454-198809000-00009. [DOI] [PubMed] [Google Scholar]
  32. Chrystie I., Totterdell B., Banatvala J. Asymptomatic endemic rotavirus infections in the newborn. Lancet. 1978;i:1176–1178. doi: 10.1016/S0140-6736(78)90967-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Clark H., Dolan K., Horton-Slight P., Palmer J., Plotkin S. Diverse serologic response to rotavirus infection of infants in a single epidemic. Pediatr. Infect. Dis. J. 1985;4:626–631. doi: 10.1097/00006454-198511000-00006. [DOI] [PubMed] [Google Scholar]
  34. Clark H., Furukawa T., Bell L., Offit P., Parrella P., Plotkin S. Immune response of infants and children to low-passage bovine rotavirus (strain WC3). Am. J. Dis. Child. 1986;140:350–356. doi: 10.1001/archpedi.1986.02140180084030. [DOI] [PubMed] [Google Scholar]
  35. Clark H., Borian F., Bell L., Modesto K., Gouvea V., Plotkin S. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J. Infect. Dis. 1988;158:570–587. doi: 10.1093/infdis/158.3.570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Clark H., Borian F., Plotkin S. Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3. J. Infect. Dis. 1990;161:1099–1104. doi: 10.1093/infdis/161.6.1099. [DOI] [PubMed] [Google Scholar]
  37. Clark H., Welsko D., Offit P. Infant responses to bovine rotavirus WC3 reassortants containing human rotavirus vp7, vp4 or vp7 + vp4. Int. Conf. Antimicrob. Agents Chemother., Anaheim, Calif. 1992:343. [Google Scholar]
  38. Clemens J., Ward R., Rao M., Sack D., Knowlton D., Van Loon F., Huda S., McNeal M., Ahmed F., Schiff G. Seroepidemiologic evaluation of antibodies to rotavirus as correlates of the risk of clinically significant rotavirus diarrhea in rural Bangladesh. J. Infect. Dis. 1992;165:161–165. doi: 10.1093/infdis/165.1.161. [DOI] [PubMed] [Google Scholar]
  39. Conner M., Estes M., Graham D. Rabbit model of rotavirus infection. J. Virol. 1988;62:1625–1633. doi: 10.1128/jvi.62.5.1625-1633.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Conner M., Gilger M., Estes M., Graham D. Serologic and mucosal immune response to rotavirus infection in the rabbit model. J. Virol. 1991;65:2562–2571. doi: 10.1128/jvi.65.5.2562-2571.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Courthier G., Vannier P. Production of coproantibodies and immune complexes in piglets infected with rotavirus. J. Infect. Dis. 1983;147:293–296. doi: 10.1093/infdis/147.2.293. [DOI] [PubMed] [Google Scholar]
  42. Coulson B., Grimwood K., Masendycz P., Lund J., Mermelstein N., Bishop R., Barnes G. Comparison of rotavirus immunoglobulin A coproconversion with other indices of rotavirus infection in a longitudinal study in childhood. J. Clin. Microbiol. 1990;28:1367–1374. doi: 10.1128/jcm.28.6.1367-1374.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Coulson B., Grimwood K., Hudson I., Barnes G., Bishop R. Role of coproantibody in clinical protection of children during reinfection with rotavirus. J. Clin. Microbiol. 1992;30:1678–1684. doi: 10.1128/jcm.30.7.1678-1684.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Crawford S., Conner M., Barone C., Cohen J., Estes M. Characterization of rotavirus subunit vaccine produced in insect cells. Int. Symp. Double-Stranded RNA Viruses, 4th, Scottsdale, Ariz. Abstr. 1992:54–57. [Google Scholar]
  45. Cukor G., Blacklow N., Capozza F., Panjvani Z., Bednarek F. Persistence of antibodies to rotavirus in human milk. J. Clin. Microbiol. 1979;9:93–96. doi: 10.1128/jcm.9.1.93-96.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Cushing A., Anderson L. Diarrhea in breast-fed and non-breast-fed infants. Pediatrics. 1982;70:921–925. [PubMed] [Google Scholar]
  47. Czerkinsky C., Prince S., Michalek S., Jackson S., Russell M., Moldoveanu Z., McGhee J., Mestecky J. IgA antibody-producing cells in peripheral blood after antigen ingestion: Evidence for a common mucosal immune system in humans. Proc. Natl. Acad. Sci. U.S.A. 1987;84:2449–2453. doi: 10.1073/pnas.84.8.2449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Dagan R., Kassis I., Sarov B., Midthun K., Davidson B., Vesikari T., Sarov I. Safety and immunogenicity of oral tetravalent human-rhesus reassortant rotavirus vaccine in neonates. Pediatr. Infect. Dis. J. 1992;11:991–996. doi: 10.1097/00006454-199211120-00001. [DOI] [PubMed] [Google Scholar]
  49. Davidson G., Goller J., Bishop R., Townley R., Holmes I., Ruck B. Immunofluorescence in duodenal mucosal of children with acute enteritis due to a new virus. J. Clin. Pathol. 1975;28:263–266. doi: 10.1136/jcp.28.4.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Davidson G., Hogg R., Kirubakaran C. Serum and intestinal immune response to rotavirus enteritis in children. Infect. Immun. 1983;40:447–452. doi: 10.1128/iai.40.2.447-452.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Davidson G., Daniels E., Nunan H., Moore A., Whyte P., Franklin K., McCloud P., Moore D. Passive immunization of children with bovine colostrum containing antibodies to human rotavirus. Lancet. 1989;i:709–712. doi: 10.1016/s0140-6736(89)90771-x. [DOI] [PubMed] [Google Scholar]
  52. De Champs C., Laveran H., Peigue-Lafeville H., Chambon M., Demeocq F., Gaulme J., Beytout D. Sequential rotavirus infections: Characterization of serotypes and electropherotypes. Res. Virol. 1991;142:39–45. doi: 10.1016/0923-2516(91)90026-y. [DOI] [PubMed] [Google Scholar]
  53. De Mol P., Zissis G., Butzler J., Mutwewingabo A., Andre F. Failure of live, attenuated oral rotavirus vaccine. Lancet. 1986;i:108. doi: 10.1016/s0140-6736(86)91643-0. [DOI] [PubMed] [Google Scholar]
  54. Dharakul T., Riepenhoff-Talty M., Albini B., Ogra P.L. Distribution of rotavirus antigen in intestinal lymphoid tissues: Potential role in development of the mucosal immune response to rotavirus. Clin. Exp. Immunol. 1988;74:14–19. [PMC free article] [PubMed] [Google Scholar]
  55. Dharakul T., Rott L., Greenberg H. Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: Virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes. J. Virol. 1990;64:4375–4382. doi: 10.1128/jvi.64.9.4375-4382.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Dharakul T., Labbe M., Cohen J., Bellamy A., Street J., Mackow E., Fiore L., Rott L., Greenberg H. Immunization with baculovirus-expressed recombinant rotavirus proteins vp1, vp4, vp6, and vp7 induces CD8+ T lymphocytes that mediate clearance of chronic rotavirus infection in SCID mice. J. Virol. 1991;65:5928–5932. doi: 10.1128/jvi.65.11.5928-5932.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Dormitzer P., Ho D., Mackow E., Mocarski E., Greenberg H. Neutralizing epitopes on herpes simplex-1-expressed rotavirus vp7 are dependent on coexpression of other rotavirus proteins. Virology. 1992;187:18–32. doi: 10.1016/0042-6822(92)90291-v. [DOI] [PubMed] [Google Scholar]
  58. Duffy L., Byers Riepenhoff-Talty T., La Seolea L., Zielezny M., Ogra P. The effects of infant feeding on rotavirus-induced gastroenteritis: A prospective study. Am. J. Public Health. 1986;76:259–263. doi: 10.2105/ajph.76.3.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Duffy L., Riepenhoff-Talty M., Byers T., La Scolea L., Zielezny M., Dryja D., Ogra P. Modulation of rotavirus enteritis during breast-feeding. Am. J. Dis. Child. 1986;140:1164–1168. doi: 10.1001/archpedi.1986.02140250090041. [DOI] [PubMed] [Google Scholar]
  60. Estes M., Cohen J. Rotavirus gene structure and function. Microbiol. Rev. 1989;53:410–449. doi: 10.1128/mr.53.4.410-449.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Estes M., Palmer E., Obijeski J. Rotaviruses: A review. Curr. Top. Microbiol. Immunol. 1983;105:123–184. doi: 10.1007/978-3-642-69159-1_3. [DOI] [PubMed] [Google Scholar]
  62. Evavold B., Allen P. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science. 1991;252:1308–1310. doi: 10.1126/science.1833816. [DOI] [PubMed] [Google Scholar]
  63. Faden H., Modlin J., Thoms M., McBean A., Ferdon M., Ogra P. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: Systemic and local immune responses. J. Infect. Dis. 1990;162:1291–1297. doi: 10.1093/infdis/162.6.1291. [DOI] [PubMed] [Google Scholar]
  64. Flores J., Gonzalez M., Perez M., Cunto W., Perez-Schael I., Garcia D., Daoud N., Chanock R., Kapikian A. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants. Lancet. 1987;i:882–884. doi: 10.1016/s0140-6736(87)92858-3. [DOI] [PubMed] [Google Scholar]
  65. Flores J., Taniguchi K., Green K., Perez-Schael I., Garcia D., Sears J., Urasawa S., Kapikian A. Relative frequencies of rotavirus serotypes 1, 2, 3, and 4 in Venezuelan infants with gastroenteritis. J. Clin. Microbiol. 1988;26:2092–2095. doi: 10.1128/jcm.26.10.2092-2095.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Flores J., Perez-Schael I., Blanco M., Vilar M., Garcia D., Perez M., Daoud N., Midthun K., Kapikian A. Reactions to and antigenicity of two humanrhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants. J. Clin. Microbiol. 1989;27:512–518. doi: 10.1128/jcm.27.3.512-518.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Franco M., Prieto I., Labbe M., Poncet D., Borras-Cuesta F., Cohen J. Identification of cytotoxic T cell epitopes on the vp7 rotaviral protein. Int. Symp. Double-Stranded RNA Viruses, 4th, Scottsdale, Ariz. Abstr. 1992:S6–S8. [Google Scholar]
  68. Friedman M., Gaul A., Sarov B., Margalith M., Katzir G., Midthun K., Taniguchi K., Urasawa S., Kapikian A., Edelman R., Sarov I. Two sequential outbreaks of rotavirus gastroenteritis: evidence for symptomatic and asymptomatic reinfection. J. Infect. Dis. 1988;158:814–822. doi: 10.1093/infdis/158.4.814. [DOI] [PubMed] [Google Scholar]
  69. Fuhrman J., Cebra J. Special features of the priming process for secretory IgA response: B cell priming with cholera toxin. J. Exp. Med. 1981;153:534–544. doi: 10.1084/jem.153.3.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Gaul S., Simpson T., Woode G., Fulton R. Antigenic relationships among some animals rotaviruses: Virus neutralization in vitro and cross-protection in piglets. J. Clin. Microbiol. 1982;16:495–503. doi: 10.1128/jcm.16.3.495-503.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Gentsch J., Glass R., Woods P., Gouvea V., Gorziglia M., Flores J., Das B., Bhan M. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J. Clin. Microbiol. 1992;30:1365–1373. doi: 10.1128/jcm.30.6.1365-1373.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Georges-Courbot M., Monges J., Beraud-Cassel A., Gouandika I., Georges A. Prospective longitudinal study of rotavirus infections in children from birth to two years of age in Central Africa. Ann. Inst. Pasteur/Virol. 1988;139:421–428. doi: 10.1016/s0769-2617(88)80077-7. [DOI] [PubMed] [Google Scholar]
  73. Georges-Courbot M., Monges J., Siopathis M., Roungou J., Gresenguet G., Bellec L., Bouquety J., Lanckriet C., Cadoz M., Hessel L., Gouvea V., Clark F., Georges A. Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res. Virol. 1991;142:405–411. doi: 10.1016/0923-2516(91)90008-q. [DOI] [PubMed] [Google Scholar]
  74. Gerna G., Sarasini Z., Torsellini M., Torre D., Parea M., Battaglia M. Group- and type-specific serologic response in infants and children with primary rotavirus infections and gastroenteritis caused by a strain of known serotype. J. Infect. Dis. 1990;161:1105–1111. doi: 10.1093/infdis/161.6.1105. [DOI] [PubMed] [Google Scholar]
  75. Glass R., Svennerholm A., Stoll B., Khan M., Hossain K., Huq I., Holmgren J. Protection against cholera in breast-fed children by antibodies in breast milk. N. Engl. J. Med. 1983;308:1389–1392. doi: 10.1056/NEJM198306093082304. [DOI] [PubMed] [Google Scholar]
  76. Glass R., Stoll B., Wyatt R., Hoshino Y., Banu H., Kapikian A. Observations questioning a protective role for breast-feeding in severe rotavirus diarrhea. Acta Pediatr. Scand. 1986;75:713–718. doi: 10.1111/j.1651-2227.1986.tb10279.x. [DOI] [PubMed] [Google Scholar]
  77. Goldblum R., Ahlstedt S., Carlsson B., Hanson L., Jodal V., Lider-Janson G., Sohl-Akerlund A. Antibody-forming cells in human colostrum after oral immunization. Nature (London) 1975;257:797–799. doi: 10.1038/257797a0. [DOI] [PubMed] [Google Scholar]
  78. Gorziglia M., Larralde G., Kapikian A., Chanock R. Antigenic relationships among human rotaviruses as determined by outer capsid protein vp4. Proc. Natl. Acad. Sci. U.S.A. 1990;87:7155–7159. doi: 10.1073/pnas.87.18.7155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Gothefors L., Wadell G., Juto P., Taniguchi K., Kapikian A., Glass R. Prolonged efficacy of rhesus rotavirus vaccine in Swedish children. J. Infect. Dis. 1990;159:753–757. doi: 10.1093/infdis/159.4.753. [DOI] [PubMed] [Google Scholar]
  80. Green K., Kapikian A. Identification of vp7 epitopes associated with protection against human rotavirus illness or shedding in volunteers. J. Virol. 1992;66:548–553. doi: 10.1128/jvi.66.1.548-553.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Green K., Taniguchi K., Mackow E., Kapikian A. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccines: Implications for vaccine development. J. Infect. Dis. 1990;161:667–679. doi: 10.1093/infdis/161.4.667. [DOI] [PubMed] [Google Scholar]
  82. Greenberg H., Vo P., Jones R. Cultivation and characterization of three strains of murine rotavirus. J. Virol. 1986;57:585–590. doi: 10.1128/jvi.57.2.585-590.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Greenberg H., Clark F., Offit P. Rotavirus pathology and pathophysiology. Curr. Top. Microbiol. Immunol. 1993 doi: 10.1007/978-3-642-78256-5_9. in press. [DOI] [PubMed] [Google Scholar]
  84. Grimwood K., Lund J., Coulson B., Hudson I., Bishop R., Barnes G. Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children. J. Clin. Microbiol. 1988;26:732–738. doi: 10.1128/jcm.26.4.732-738.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Grinstein S., Gomez J., Bercovich J., Biscorn E. Epidemiology of rotavirus infection and gastroenteritis in prospectively monitored Argentine families with young children. Am. J. Epidemiol. 1989;130:300–308. doi: 10.1093/oxfordjournals.aje.a115336. [DOI] [PubMed] [Google Scholar]
  86. Grunow J., Dunton S., Waner J. Human rotavirus-like particles in a hepatic abscess. J. Pediatr. 1985;106:73–76. doi: 10.1016/s0022-3476(85)80470-4. [DOI] [PubMed] [Google Scholar]
  87. Guarino A., Guandalini S., Albano F., Mascia A., Ritis G., Rubino A. Enteral immunoglobulins for treatment of protracted rotaviral diarrhea. Pediatr. Infect. Dis. J. 1991;10:612–614. doi: 10.1097/00006454-199108000-00010. [DOI] [PubMed] [Google Scholar]
  88. Guy-Grand D., Griscelli C., Vassali P. The mouse gut T lymphocyte, a novel type of cell: Nature, origin, and traffic in mice in normal and graft-versus-host conditions. J. Exp. Med. 1978;148:1661–1677. doi: 10.1084/jem.148.6.1661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Hambraeus A., Hambraeus L., Wadell G. Animal model of rotavirus infection in rabbits—protection obtained without shedding of viral antigen. Arch. Virol. 1989;107:237–251. doi: 10.1007/BF01317920. [DOI] [PubMed] [Google Scholar]
  90. Hanlon P., Marsh V., Shenton F., Jobe O., Hayes R., Whittle H., Hanlon L., Byass P., Hassan-King M., Sillahm' H., Boge B., Greenwood B. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet. 1987;i:1342–1345. doi: 10.1016/s0140-6736(87)90649-0. [DOI] [PubMed] [Google Scholar]
  91. Hattori H., Torii S., Nagafuji H., Tabata Y., Hata A. Benign acute myositis associated with rotavirus gastroenteritis. J. Pediatr. 1992;121:748–749. doi: 10.1016/s0022-3476(05)81908-0. [DOI] [PubMed] [Google Scholar]
  92. Haug K., Orstavik I., Kvelstad G. Rotavirus infections in families: A clinical and virological study. Scand. J. Infect. Dis. 1978;10:265–269. doi: 10.3109/inf.1978.10.issue-4.02. [DOI] [PubMed] [Google Scholar]
  93. Hilpert H., Brussow H., Mietens C., Sidoti J., Lerner L., Werchau H. Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J. Infect. Dis. 1987;156:158–165. doi: 10.1093/infdis/156.1.158. [DOI] [PubMed] [Google Scholar]
  94. Ho M., Glass R., Pinsky P., Anderson L. Rotavirus as a cause of diarrheal morbidity and mortality in the U.S. J. Infect. Dis. 1988;158:1112–1116. doi: 10.1093/infdis/158.5.1112. [DOI] [PubMed] [Google Scholar]
  95. Ho M., Glass R., Pinsky P., Young-Okoh N., Sappenfield W., Buehler J., Gunter N., Anderson L. Diarrheal diseases in American children: Are they preventable? J. Am. Med. Assoc. 1988;260:3281–3285. [PubMed] [Google Scholar]
  96. Hoshino Y., Sereno M., Midthun K., Flores J., Kapikian A., Chanock R. Independent segregation of two antigenic specificities (vp3 and vp7) involved in neutralization of rotavirus infectivity. Proc. Natl. Acad. Sci. U.S.A. 1985;82:8701–8704. doi: 10.1073/pnas.82.24.8701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Hoshino Y., Saif L., Sereno M., Chanock R., Kapikian A. Infection immunity of piglets to either vp3 or vp7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen. J. Virol. 1988;62:744–748. doi: 10.1128/jvi.62.3.744-748.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Ijaz M., Attah-Poku S., Redmund M., Parker M., Sabara M., Babiuk L. Heterotypic passive protection induced by synthetic peptides corresponding to vp7 and vp4 of bovine rotavirus. J. Virol. 1991;65:3106–3113. doi: 10.1128/jvi.65.6.3106-3113.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Jayashree S., Bhan M., Raj P., Kumar R., Svensson L., Stintzing G., Bhandari N. Neonatal rotavirus infection and its relation to cord blood antibodies. Scand. J. Infect. Dis. 1988;20:249–253. doi: 10.3109/00365548809032447. [DOI] [PubMed] [Google Scholar]
  100. Kapikian A., Kim H., Wyatt R., Cline W., Arrobio J., Brandt C., Rodriguez W., Sack D., Chanock R., Parrot R. Human reovirus-like agent as the major pathogen associated with “winter” gastroenteritis in hospitalized infants and young children. N. Engl. J. Med. 1976;294:965–972. doi: 10.1056/NEJM197604292941801. [DOI] [PubMed] [Google Scholar]
  101. Kapikian A., Wyatt R., Levine M., Yolken R., Van Kirk D., Dolin R., Greenberg H., Chanock R. Oral administration of human rotavirus to volunteers: Induction of illness and correlates of resistance. J. Infect. Dis. 1983;147:95–106. doi: 10.1093/infdis/147.1.95. [DOI] [PubMed] [Google Scholar]
  102. Kim H., Brandt C., Kapikian A., Wyatt R., Arrobio J., Rodriguez W., Chanock R., Parrott R. Human reovirus-like agent infection; occurrence in adult contacts of pediatric patients with gastroenteritis. J. Am. Med. Assoc. 1977;238:404–407. doi: 10.1001/jama.238.5.404. [DOI] [PubMed] [Google Scholar]
  103. Kitaoka S., Fukuhara N., Tazawa F., Suzuki H., Sato T., Konno T., Ebina T., Ishida N. Characterization of monoclonal antibodies against human rotavirus hemagglutinin. J. Med. Virol. 1986;19:313–323. doi: 10.1002/jmv.1890190404. [DOI] [PubMed] [Google Scholar]
  104. Lanata C., Black R., del Aguila R., Gil A., Verastegui H., Gerna G., Flores S., Kapikian A., Andre F. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J. Infect. Dis. 1989;159:452–459. doi: 10.1093/infdis/159.3.452. [DOI] [PubMed] [Google Scholar]
  105. Le Baron C., Lew J., Glass R., Weber J., Ruiz-Palacios G. Rotavirus Study Group. Annual rotavirus epidemic patterns in North America. J. Am. Med. Assoc. 1990;264:983–988. doi: 10.1001/jama.264.8.983. [DOI] [PubMed] [Google Scholar]
  106. Lecce J., Leary H., Clare D., Batema R. Protection of agammaglobulinemic piglets from porcine rotavirus infection by antibody against simian rotavirus SA-11. J. Clin. Microbiol. 1991;29:1382–1386. doi: 10.1128/jcm.29.7.1382-1386.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Linares A., Gabbay Y., Mascarenhas J., Freitas R., Flewett T., Beards G. Epidemiology of rotavirus subgroups and serotypes in Belem, Brazil: A three-year study. Ann. Inst. Pasteur/Virol. 1988;139:89–99. doi: 10.1016/s0769-2617(88)80009-1. [DOI] [PubMed] [Google Scholar]
  108. Losonsky G., Reymann M. The immune response in primary asymptomatic and symptomatic rotavirus infection in newborn infants. J. Infect. Dis. 1990;161:330–332. doi: 10.1093/infdis/161.2.330. [DOI] [PubMed] [Google Scholar]
  109. Losonsky G., Vonderfecht S., Eiden J., Wee S., Yolken R. Homotypic and heterotypic antibodies for prevention of experimental rotavirus gastroenteritis. J. Clin. Microbiol. 1986;24:1041–1044. doi: 10.1128/jcm.24.6.1041-1044.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Losonsky G., Rennels M., Kapikian A., Midthun K., Ferra P., Fortier D., Hoffman K., Baig A., Levine M. Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants. Pediatr. Infect. Dis. J. 1986;5:25–29. doi: 10.1097/00006454-198601000-00005. [DOI] [PubMed] [Google Scholar]
  111. Losonsky G., Rennels M., Lim Y., Krall G., Kapikian A., Levine M. Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006. Pediatr. Infect. Dis. J. 1988;7:388–393. doi: 10.1097/00006454-198806000-00004. [DOI] [PubMed] [Google Scholar]
  112. Mackow E., Shaw R., Matsui S., Vo P., Dang M., Greenberg H. The rhesus rotavirus gene encoding vp3; location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc. Natl. Acad. Sci. U.S.A. 1988;85:645–649. doi: 10.1073/pnas.85.3.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Mackow E., Vo P., Broome R., Bass D., Greenberg H. Immunization with baculovirus-expressed vp4 protein passively protects against simian and murine rotavirus challenge. J. Virol. 1990;64:1698–1703. doi: 10.1128/jvi.64.4.1698-1703.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Madore H., Christy C., Pichichero M., Long C., Pincas P., Vosefsky D., Kapikian A., Dolin R. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of vp7 serotype 3 or 1 specificity in infants. J. Infect. Dis. 1992;166:235–243. doi: 10.1093/infdis/166.2.235. [DOI] [PubMed] [Google Scholar]
  115. Maldonado Y., Hestvik L., Wilson M., Townsend T., O'Hare J., Wee S., Yolken R. Safety and immunogenicity of bovine rotavirus vaccine RIT 4237 in 3-month-old infants. J. Pediatr. 1986;109:931–935. doi: 10.1016/s0022-3476(86)80271-2. [DOI] [PubMed] [Google Scholar]
  116. Mata L., Simhon A., Urratia J., Kronmal R., Fernandez R., Garcia B. Epidemiology of rotaviruses in a cohort of 45 Guatemalan Mayan Indian children observed from birth to the age of three years. J. Infect. Dis. 1983;148:452–461. doi: 10.1093/infdis/148.3.452. [DOI] [PubMed] [Google Scholar]
  117. Matson D., Estes M. Impact of rotavirus infection at a large pediatric hospital. J. Infect. Dis. 1990;162:598–604. doi: 10.1093/infdis/162.3.598. [DOI] [PubMed] [Google Scholar]
  118. Matson D., Estes M., Burns J., Greenberg H., Taniguchi K., Urasawa S. Serotype variation of human group A rotaviruses in two regions of the USA. J. Infect. Dis. 1990;162:605–614. doi: 10.1093/infdis/162.3.605. [DOI] [PubMed] [Google Scholar]
  119. Matson D., O'Ryan M., Pickering L., Chiba S., Nakata S., Raj P., Estes M. Characterization of serum antibody responses to natural rotavirus infections in children by vp7-specific epitope-blocking assays. J. Clin. Microbiol. 1992;30:1056–1061. doi: 10.1128/jcm.30.5.1056-1061.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Matson D., O'Ryan M., Herrera I., Pickering L., Estes M. Fecal antibody responses to symptomatic and asymptomatic rotavirus infections. J. Infect. Dis. 1993;167:577–583. doi: 10.1093/infdis/167.3.577. [DOI] [PubMed] [Google Scholar]
  121. Matsui S., Mackow E., Greenberg H. Molecular determinant of rotavirus neutralization and protection. Adv. Virus Res. 1989;36:181–214. doi: 10.1016/s0065-3527(08)60585-0. [DOI] [PubMed] [Google Scholar]
  122. Matsui S., Offit P., Vo P., Mackow E., Benfield D., Shaw R., Padilla-Noriega L., Greenberg H. Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of vp7 and the vp8 fragment of vp4. J. Clin. Microbiol. 1989;27:780–782. doi: 10.1128/jcm.27.4.780-782.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Matsuno S., Utagawa E., Sugiura A. Association of rotavirus infection with Kawasaki syndrome. J. Infect. Dis. 1983;148:177. doi: 10.1093/infdis/148.1.177. [DOI] [PubMed] [Google Scholar]
  124. Mattion N., Mitchell D., Both G., Estes M. Expression of rotavirus proteins encoded by alternative open reading frames of genome segment 11. Virology. 1991;181:295–304. doi: 10.1016/0042-6822(91)90495-w. [DOI] [PubMed] [Google Scholar]
  125. McNeal M., Sheridan J., Ward R. Active protection against rotavirus infection of mice following intraperitoneal immunization. Virology. 1992;191:150–157. doi: 10.1016/0042-6822(92)90176-p. [DOI] [PubMed] [Google Scholar]
  126. Mebus C. Reovirus-like calf enteritis. Dig. Dis. Sci. 1976;21:592–598. doi: 10.1007/BF01464768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Mebus C., White R., Bass E., Twiehaus M. Immunity to neonatal calf diarrhea virus. J. Am. Vet. Med. Assoc. 1973;163:880–883. [Google Scholar]
  128. Merchant A., Groene W., Cheng E., Shaw R. Murine intestinal antibody response to heterologous rotavirus infection. J. Clin. Microbiol. 1991;29:1693–1701. doi: 10.1128/jcm.29.8.1693-1701.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Midthun K., Greenberg H., Hoshino Y., Kapikian A., Wyatt R., Chanock R. Reassortant rotaviruses as potential live rotavirus vaccine candidates. J. Virol. 1985;53:949–954. doi: 10.1128/jvi.53.3.949-954.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Midthun Hoshino Y., Kapikian A., Chanock R. Single gene substitution rotavirus reassortants containing the major neutralization protein (vp7) of human rotavirus serotype 4. J. Clin. Microbiol. 1986;24:822–826. doi: 10.1128/jcm.24.5.822-826.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Midthun K., Pang L., Flores J., Kapikian A. Comparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque-reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates. J. Clin. Microbiol. 1989;27:2799–2804. doi: 10.1128/jcm.27.12.2799-2804.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Midthun K., Halsey N., Jett-Goheen M., Clements M., Steinhoff M., King J., Karron R., Wilson M., Burns B., Perkis V., Samorodin R., Kapikian A. Safety and immunogenicity of human rotavirus vaccine strain M37 in adults, children, and infants. J. Infect. Dis. 1991;164:792–796. doi: 10.1093/infdis/164.4.792. [DOI] [PubMed] [Google Scholar]
  133. Nishikawa K., Fukuhara N., Liprandi F., Green K., Kapikian A., Chanock R., Gorziglia M. Vp4 protein of porcine rotavirus strain OSU expressed by a baculovirus recombinant induces neutralizing antibodies. Virology. 1989;173:631–637. doi: 10.1016/0042-6822(89)90575-8. [DOI] [PubMed] [Google Scholar]
  134. Noel J., Beards G., Cubitt W. Epidemiological survey of human rotavirus serotypes and electropherotypes in young children admitted to two children's hospitals in northeast London from 1984 to 1990. J. Clin. Microbiol. 1991;29:2213–2219. doi: 10.1128/jcm.29.10.2213-2219.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Offit P., Blavat G. Identification of the two rotavirus genes determining neutralization specificities. J. Virol. 1986;57:376–378. doi: 10.1128/jvi.57.1.376-378.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Offit P., Clark H. Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J. Virol. 1985;54:58–64. doi: 10.1128/jvi.54.1.58-64.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Offit P., Clark H. Maternal antibody-mediated protection against gastroenteritis due to rotavirus in newborn mice is dependent on both serotype and titer of antibody. J. Infect. Dis. 1985;152:1152–1158. doi: 10.1093/infdis/152.6.1152. [DOI] [PubMed] [Google Scholar]
  138. Offit P., Dudzik K. Rotavirus-specific cytotoxic T lymphocytes cross-react with target cells infected with different rotavirus serotypes. J. Virol. 1988;62:127–131. doi: 10.1128/jvi.62.1.127-131.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Offit P., Dudzik K. Noninfectious rotavirus (strain RRV) induces an immune response in mice which protects against rotavirus challenge. J. Clin. Microbiol. 1989;27:885–888. doi: 10.1128/jcm.27.5.885-888.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Offit P., Dudzik K. Rotavirus-specific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection. J. Virol. 1989;63:3507–3512. doi: 10.1128/jvi.63.8.3507-3512.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Offit P., Dudzik K. Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice. J. Virol. 1990;64:6325–6328. doi: 10.1128/jvi.64.12.6325-6328.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Offit P., Clark H., Kornstein M., Plotkin S. A murine model for oral infection with a primate rotavirus (simian SA11). J. Virol. 1984;51:233–236. doi: 10.1128/jvi.51.1.233-236.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Offit P., Clark H., Blavat G., Greenberg H. Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype. J. Virol. 1986;60:491–496. doi: 10.1128/jvi.60.2.491-496.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Offit P., Shaw R., Greenberg H. Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J. Virol. 1986;58:700–703. doi: 10.1128/jvi.58.2.700-703.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Offit P., Cunningham S., Dudzik K. Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection. J. Virol. 1991;65:1318–1324. doi: 10.1128/jvi.65.3.1318-1324.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Offit P., Boyle D., Both G., Hill N., Svoboda Y., Cunningham S., Jenkins R., McRae M. Outer capsid glycoprotein vp7 is recognized by cross-reactive, rotavirus-specific, cytotoxic T lymphocytes. Virology. 1991;184:563–568. doi: 10.1016/0042-6822(91)90426-c. [DOI] [PubMed] [Google Scholar]
  147. Offit P., Hoffenberg E., Santos N., Gouvea V. Rotavirus-specific humoral and cellular immune response after primary, symptomatic infection. J. Infect. Dis. 1993;167:1436–1440. doi: 10.1093/infdis/167.6.1436. [DOI] [PubMed] [Google Scholar]
  148. Offit P., Coupar B., Suoboda J., Jenkins R., McRae M., Abraham A., Hill N., Boyle P., Andrew M., Both G. Induction of rotavirus-specific cytotoxic T lymphocytes by vaccinia virus recombinants expressing individual rotavirus genes. Virology. 1994;198:10–16. doi: 10.1006/viro.1994.1002. [DOI] [PubMed] [Google Scholar]
  149. Onorato I., Modlin J., McBean A., Thomas M., Losonsky G., Bernier R. Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines. J. Infect. Dis. 1991;163:1–6. doi: 10.1093/infdis/163.1.1. [DOI] [PubMed] [Google Scholar]
  150. O'Ryan M., Matson D., Estes M., Bartlett A., Pickering L. Molecular epidemiology of rotavirus in young children attending day care centers in Houston. J. Infect. Dis. 1990;162:810–816. doi: 10.1093/infdis/162.4.810. [DOI] [PubMed] [Google Scholar]
  151. Otnaess A., Orstavik I. The effect of human milk fractions on rotavirus in relation to the secretory IgA content. Acta Pathol. Microbiol. Scand. 1980;88:15–21. doi: 10.1111/j.1699-0463.1980.tb00067.x. [DOI] [PubMed] [Google Scholar]
  152. Padilla-Noriega L., Arias C., Lopez S., Puerto F., Snodgrass D., Taniguchi K., Greenberg H. Diversity of rotavirus serotypes in Mexican infants with gastroenteritis. J. Clin. Microbiol. 1990;28:1114–1119. doi: 10.1128/jcm.28.6.1114-1119.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Padilla-Noriega L., Fiore L., Rennels M., Losonsky G., Mackow E., Greenberg H. Humoral immune responses to vp4 and its cleavage products vp5* and vp8* in infants vaccinated with rhesus rotavirus. J. Clin. Microbiol. 1992;30:1392–1397. doi: 10.1128/jcm.30.6.1392-1397.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Perez-Schael I., Daoud G., White L., Urbina G., Daoud N., Perez M., Flores J. Rotavirus shedding by newborn children. J. Med. Virol. 1984;14:127–136. doi: 10.1002/jmv.1890140206. [DOI] [PubMed] [Google Scholar]
  155. Perez-Schael I., Gonzalez M., Daoud N., Perez Soto M.I., Garcia D., Daoud G., Kapikian A., Flores J. Reactogenicity and antigenicity of the rhesus rotavirus vaccine in Venezuelan children. J. Infect. Dis. 1987;155:334–338. doi: 10.1093/infdis/155.2.334. [DOI] [PubMed] [Google Scholar]
  156. Perez-Schael I., Garcia D., Gonzalez M., Gonzalez R., Daoud N., Perez M., Cunot W., Kapikian A., Flores J. Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. J. Med. Virol. 1990;30:219–229. doi: 10.1002/jmv.1890300315. [DOI] [PubMed] [Google Scholar]
  157. Perez-Schael I., Blanco M., Vilar M., Garcia D., White L., Gonzalez R., Kapikian A., Flores J. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants. J. Clin. Microbiol. 1990;28:553–558. doi: 10.1128/jcm.28.3.553-558.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Petit A., Ernst P., Befus A., Clark D., Rosenthal K., Ishizaka T., Bienenstock J. Murine intestinal epithelial lymphocytes. I. Relationship of a novel Thy1−, Lyt1−, Lyt2+ granulated subpopulation to natural killer cells and mast cells. Eur. J. Immunol. 1985;15:211–215. doi: 10.1002/eji.1830150302. [DOI] [PubMed] [Google Scholar]
  159. Puerto F., Padilla-Noriega L., Zamora-Chavez A., Briceno A., Puerto M., Arias C. Prevalent patterns of serotype-specific seroconversion in Mexican children infected with rotavirus. J. Clin. Microbiol. 1987;25:960–963. doi: 10.1128/jcm.25.5.960-963.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Quiding M., Nordstrom I., Kilander A., Andersson G., Hanson L., Holmgren J., Czerkinsky C. Intestinal immune response in humans: Oral cholera vaccination induces strong intestinal antibody responses and interferon-g production and evokes local immunological memory. J. Clin. Invest. 1991;88:143–148. doi: 10.1172/JCI115270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Redmond M., Ijaz M., Parker M., Sabara M., Dent D., Gibbons E., Babiuk L. Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential. Vaccine. 1993;11:273–281. doi: 10.1016/0264-410x(93)90029-w. [DOI] [PubMed] [Google Scholar]
  162. Rennels M., Losonsky G., Levine M., Kapikian A. The Clinical Study Group Preliminary evaluation of the efficacy of rhesus rotavirus vaccine strain MMU 18006 in young children. Pediatr. Infect. Dis. J. 1986;5:587–588. doi: 10.1097/00006454-198609000-00019. [DOI] [PubMed] [Google Scholar]
  163. Rennels M., Losonsky G., Shindledecker C., Hughes T., Kapikian A., Levine M. And the Clinical Study Group Immunogenicity and reactogenicity of lowered doses of rhesus rotavirus vaccine strain MMU 18006 in young children. Pediatr. Infect. Dis. J. 1987;6:260–264. doi: 10.1097/00006454-198703000-00010. [DOI] [PubMed] [Google Scholar]
  164. Rennels M., Losonsky G., Young A., Shindledecker C., Kapikian A., Levine M. The Clinical Study Group An efficacy trial of the rhesus rotavirus vaccine in Maryland. Am. J. Dis. Child. 1990;144:601–604. doi: 10.1001/archpedi.1990.02150290095037. [DOI] [PubMed] [Google Scholar]
  165. Reves R., Hossain M., Midthun K., Kapikian A., Naguib T., Zaki A., Dupont H. An observational study of naturally-acquired immunity to rotavirus diarrhea in a cohort of 363 Egyptian children. Am. J. Epidemiol. 1989;130:981–988. doi: 10.1093/oxfordjournals.aje.a115431. [DOI] [PubMed] [Google Scholar]
  166. Riepenhoff-Talty M., Bogger-Goren S., Li P., Carmody P., Barrett H., Ogra P. Development of serum and intestinal antibody response to rotavirus after naturally acquired rotavirus infection in man. J. Med. Virol. 1981;8:215–222. doi: 10.1002/jmv.1890080309. [DOI] [PubMed] [Google Scholar]
  167. Riesen W., Offit P. Intestinal rotavirus-specific helper T cell response in mice after acute infection. Int. Symp. Double-Stranded RNA Viruses, 4th, Scottsdale, Ariz. Abstr. 1992:31. [Google Scholar]
  168. Ringenbergs M., Albert M., Davidson G., Goldsworthy W., Haslam R. Serotype-specific antibodies to rotavirus in human colostrum and breast milk and in maternal and cord blood. J. Infect. Dis. 1988;158:477–480. doi: 10.1093/infdis/158.2.477. [DOI] [PubMed] [Google Scholar]
  169. Rodriguez W., Kim H., Arrobio J., Brandt C., Chanock R., Kapikian A., Wyatt R., Parrot R. Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young children. J. Pediatr. 1977;91:188–193. doi: 10.1016/S0022-3476(77)80810-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Rodriguez W., Kim H., Brandt C., Yolken R., Richard, Arrobio M.J., Schwartz R., Kapikian A., Chanock R., Parrott R. Common exposure outbreak of gastroenteritis due to type 2 rotavirus with high secondary attack rate within families. J. Infect. Dis. 1979;140:353–357. doi: 10.1093/infdis/140.3.353. [DOI] [PubMed] [Google Scholar]
  171. Rodriguez W., Kim H., Brandt C., Schwartz R., Gardner M., Jeffries B., Parrott R., Kaslow R., Smith J., Kapikian A. Longitudinal study of rotavirus infection and gastroenteritis in families served by a pediatric medical practice: Clinical and epidemiologic observations. Pediatr. Infect. Dis. J. 1987;6:170–176. doi: 10.1097/00006454-198702000-00006. [DOI] [PubMed] [Google Scholar]
  172. Rotbart H., Levin M., Yolken R., Manchester D., Jantzen J. An outbreak of rotavirus-associated necrotizing enterocolitis. J. Pediatr. 1983;103:454–459. doi: 10.1016/S0022-3476(83)80427-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Rotbart H., Nelson W., Glade M., Triffon T., Kogut S., Yolken R., Hernandez J., Levin M. Neonatal rotavirus-associated necrotizing enterocolitis: Case control study and prospective surveillance during an outbreak. J. Pediatr. 1988;112:87–93. doi: 10.1016/S0022-3476(88)80128-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Ryder R., Singh N., Reeves W., Kapikian A., Greenberg H., Sack R. Evidence of immunity induced by naturally acquired rotavirus and Norwalk virus infection on two remote Panamanian islands. J. Infect. Dis. 1985;151:99–105. doi: 10.1093/infdis/151.1.99. [DOI] [PubMed] [Google Scholar]
  175. Sack D. Efficacy of rhesus rotavirus monovalent or tetravalent oral vaccines in US children. Int. Conf. Antimicrob. Agents Chemother., Anaheim, Calif. Abstr. 1992:344. [Google Scholar]
  176. Saif L. Development of nasal, fecal, and serum isotype-specific antibodies in calves challenged with bovine coronavirus or rotavirus. Vet Immunol. Immunopathol. 1987;17:425–439. doi: 10.1016/0165-2427(87)90159-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Saif L., Redman D., Smith K., Theil K. Passive imunity to bovine rotavirus in newborn calves fed colostrum supplements from immunized and unimmunized cows. Infect. Immun. 1983;41:1118–1131. doi: 10.1128/iai.41.3.1118-1131.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Saif L., Chen W., Campbell T., Van Cott J. Enumeration of antibody-secreting cells in the mucosal lymphoid tissues of pig inoculated with rotavirus. Int. Symp. Double-Stranded RNA Viruses, 4th, Scottsdale, Ariz. 1992:39. Abstr. [Google Scholar]
  179. Salmi T., Arstila P., Koivikko A. Central nervous system involvement in patients with rotavirus gastroenteritis. Scand. J. Infect. Dis. 1978;10:29–31. doi: 10.3109/inf.1978.10.issue-1.06. [DOI] [PubMed] [Google Scholar]
  180. Santosham M., Yolken R., Quiroz E., Dillman L., Oro G., Reeves W., Sack R. Detection of rotavirus in respiratory secretions of children with pneumonia. J. Pediatr. 1983;103:583–585. doi: 10.1016/s0022-3476(83)80591-5. [DOI] [PubMed] [Google Scholar]
  181. Saulsbury F., Winkelstein J., Yolken R. Chronic rotavirus infection in immunodeficiency. J. Pediatr. 1980;97:61–65. doi: 10.1016/s0022-3476(80)80131-4. [DOI] [PubMed] [Google Scholar]
  182. Schaller J., Saif L., Cordle C., Candler E., Winship T., Smith K. Prevention of human rotavirus-induced diarrhea in gnotobiotic piglets using bovine antibody. J. Infect. Dis. 1992;165:623–630. doi: 10.1093/infdis/165.4.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Shaw R., Fong K., Losonsky G., Levine M., Maldonado Y., Yolken R., Flores J., Kapikian A., Vo P., Greenberg H. Epitope-specific immune responses to rotavirus vaccination. Gastroenterology. 1987;93:941–950. doi: 10.1016/0016-5085(87)90555-5. [DOI] [PubMed] [Google Scholar]
  184. Shaw R., Groene W., Mackow E., Merchant A., Cheng E. Vp4-specific intestinal antibody response to rotavirus in a murine model of heterotypic protection. J. Virol. 1991;65:3052–3059. doi: 10.1128/jvi.65.6.3052-3059.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Shaw R., Merchant A., Groene W., Cheng E. Persistence of intestinal antibody response to heterologous rotavirus infection in a murine model beyond 1 year. J. Clin. Microbiol. 1993;31:188–191. doi: 10.1128/jcm.31.2.188-191.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Sheridan J., Eydelloth R., Vonderfecht S., Aurelian L. Virus-specific immunity in neonatal and adult mouse rotavirus infection. Infect. Immun. 1983;39:917–927. doi: 10.1128/iai.39.2.917-927.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  187. Sheridan J., Smith C., Manak M., Aurelian L. Prevention of rotavirus-induced diarrhea in neonatal mice born to dams immunized with empty capsids of simian rotavirus SA-11. J. Infect. Dis. 1984;149:434–438. doi: 10.1093/infdis/149.3.434. [DOI] [PubMed] [Google Scholar]
  188. Snodgrass D., Wells P. Rotavirus infections in lambs: Studies on passive protection. Arch. Virol. 1976;52:201–205. doi: 10.1007/BF01348017. [DOI] [PubMed] [Google Scholar]
  189. Snodgrass D., Wells P. Passive immunity in rotaviral infections. J. Am. Vet. Med. Assoc. 1978;173:565–568. [PubMed] [Google Scholar]
  190. Snodgrass D., Wells P. The immunoprophylaxis of rotavirus infections in lambs. Vet. Rec. 1978;102:146–148. doi: 10.1136/vr.102.7.146. [DOI] [PubMed] [Google Scholar]
  191. Snodgrass D., Madeley C., Well P., Angus K. Human rotavirus in lambs: Infection and passive protection. Infect. Immun. 1977;16:268–270. doi: 10.1128/iai.16.1.268-270.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Snodgrass D., Fahey K., Wells P., Campbell I., Whitelaw A. Passive immunity in calf rotavirus infections: maternal vaccination increases and prolongs immunoglobulin G1 antibody secretion in milk. Infect. Immun. 1980;28:344–349. doi: 10.1128/iai.28.2.344-349.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Snyder J., Merson M. The magnitude of the global problem of acute diarrhoeal disease; A review of active surveillance data. Bull. W.H.O. 1982;60:605–613. [PMC free article] [PubMed] [Google Scholar]
  194. Stoll B., Glass R., Hug M., Khan M., Banu H., Holt J. Epidemiologic and clinical features of patients infected with shigella who attended a diarrhea disease hospital in Bangladesh. J. Infect. Dis. 1982;146:177–183. doi: 10.1093/infdis/146.2.177. [DOI] [PubMed] [Google Scholar]
  195. Taniguchi K., Maloy W., Nishikawa K., Green K., Hoshino Y., Urasawa S., Kapikian A. Identification of cross-reactive and serotype 2-specific neutralization epitopes on vp3 of human rotavirus. J. Virol. 1988;62:2421–2426. doi: 10.1128/jvi.62.7.2421-2426.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Totterdell B., Chrystie I., Banatvala J. Cord blood and breast-milk antibodies in neonatal rotavirus infection. Brit. Med. J. 1980;ii:828–830. doi: 10.1136/bmj.280.6217.828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Totterdell B., Nicholson K., MacLeod J., Chrystie I., Banatvala J. Neonatal rotavirus infection: Role of lacteal neutralising alpha1-anti-trypsin and nonimmunoglobulin antiviral activity in protection. J. Med. Virol. 1982;10:37–44. doi: 10.1002/jmv.1890100106. [DOI] [PubMed] [Google Scholar]
  198. Urasawa S., Urasawa T., Taniguchi K., Chiba S. Serotype determination of human rotavirus isolates and antibody prevalence of pediatric population in Hokkaido, Japan. Arch. Virol. 1984;81:1–12. doi: 10.1007/BF01309292. [DOI] [PubMed] [Google Scholar]
  199. Vesikari T., Isolauri E., Delem A., d'Hondt E., Andre F., Zissis G. Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet. 1983;ii:807–811. doi: 10.1016/s0140-6736(83)90734-1. [DOI] [PubMed] [Google Scholar]
  200. Vesikari T., Isolauri E., D'Hondt E., Delem A., Andre F., Zissis G. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet. 1984;i:977–981. doi: 10.1016/s0140-6736(84)92323-7. [DOI] [PubMed] [Google Scholar]
  201. Vesikari T., Ruuska T., Bogaerts H., Delem A., Andre F. Dose-response study of RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants. Pediatr. Infect. Dis. J. 1985;4:622–625. doi: 10.1097/00006454-198511000-00005. [DOI] [PubMed] [Google Scholar]
  202. Vesikari T., Isolauri E., Delem A., d'Hondt E., Andre F., Beards G., Flewett T. Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J. Pediatr. 1985;107:189–194. doi: 10.1016/s0022-3476(85)80123-2. [DOI] [PubMed] [Google Scholar]
  203. Vesikari T., Ruuska T., Delem A., Andre F. Oral rotavirus vaccination in breast- and bottle-fed infants aged 6 to 12 months. Acta Paediatr. Scand. 1986;75:573–578. doi: 10.1111/j.1651-2227.1986.tb10253.x. [DOI] [PubMed] [Google Scholar]
  204. Vesikari T., Rautanen T., Varis T., Beards G., Kapikian A. Rhesus rotavirus candidate vaccine: Clinical trial in children vaccinated between 2 and 5 months of age. Am. J. Dis. Child. 1990;144:285–289. [PubMed] [Google Scholar]
  205. Vesikari T., Ruuska T., Delem A., Andre F., Beards G., Flewett T. Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea. Acta Pediatr. Scand. 1991;80:173–180. doi: 10.1111/j.1651-2227.1991.tb11830.x. [DOI] [PubMed] [Google Scholar]
  206. Vesikari T., Ruuska T., Koivu H., Green K., Flores J., Kapikian A. Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants. Pediatr. Infect. Dis. J. 1991;10:912–917. doi: 10.1097/00006454-199112000-00006. [DOI] [PubMed] [Google Scholar]
  207. Vesikari T., Ruuska T., Green K., Flores J., Kapikian A. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus vp7 serotype 1 or 2 specificity. Pediatr. Infect. Dis. J. 1992;11:535–542. doi: 10.1097/00006454-199207000-00006. [DOI] [PubMed] [Google Scholar]
  208. Vonderfecht S., Osburn B. Immunity to rotavirus in conventional neonatal calves. J. Clin. Microbiol. 1982;16:935–942. doi: 10.1128/jcm.16.5.935-942.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Walsh J., Warren K. Selective primary health care: An interim strategy for disease control in developing countries. N. Engl. J. Med. 1979;301:967–974. doi: 10.1056/NEJM197911013011804. [DOI] [PubMed] [Google Scholar]
  210. Ward R., Bernstein D., Young E., Sherwood J., Knowlton D., Schiff G. Human rotavirus studies in volunteers: Determination of infectious dose and serological response to infection. J. Infect. Dis. 1986;154:871–880. doi: 10.1093/infdis/154.5.871. [DOI] [PubMed] [Google Scholar]
  211. Ward R., Knowlton D., Schiff G., Hoshino Y., Greenberg H. Relative concentrations of serum neutralizing antibody to vp3 and vp7 proteins in adults infected with a human rotavirus. J. Virol. 1988;62:1543–1549. doi: 10.1128/jvi.62.5.1543-1549.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  212. Ward R., Bernstein D., Shukla R., Young E., Sherwood J., McNeal M., Walker M., Schiff G. Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J. Infect. Dis. 1989;159:79–88. doi: 10.1093/infdis/159.1.79. [DOI] [PubMed] [Google Scholar]
  213. Ward R., McNeal M., Sheridan J. Development of an adult mouse model for studies of protection against rotavirus. J. Virol. 1990;64:5070–5075. doi: 10.1128/jvi.64.10.5070-5075.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. Ward R., McNeal M., Sheridan J. Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. Virology. 1992;188:57–66. doi: 10.1016/0042-6822(92)90734-7. [DOI] [PubMed] [Google Scholar]
  215. Ward R., Clemens J., Knowlton D., Rao M., Van Loon F., Huda N., Ahmed F., Schiff G., Sack D. Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody. J. Infect. Dis. 1992;166:1251–1257. doi: 10.1093/infdis/166.6.1251. [DOI] [PubMed] [Google Scholar]
  216. Ward R., McNeal M., Sander D., Greenberg H., Bernstein D. Immunodominance of the vp4 neutralization protein of rotavirus in protective natural infections of young children. J. Virol. 1993;67:464–468. doi: 10.1128/jvi.67.1.464-468.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  217. Weinberg R., Tipton G., Klish W., Brown M. Effect of breast-feeding on morbidity in rotavirus gastroenteritis. Pediatrics. 1984;74:250–253. [PubMed] [Google Scholar]
  218. Whorwell P., Beeken W., Phillips C., Little P., Roessner K. Isolation of reovirus-like agents from patients with Crohn's disease. Lancet. 1977;i:1169–1171. doi: 10.1016/s0140-6736(77)92714-3. [DOI] [PubMed] [Google Scholar]
  219. Wong C., Price Z., Bruckner D. Aseptic meningitis in an infant with rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 1984;3:244–246. doi: 10.1097/00006454-198405000-00014. [DOI] [PubMed] [Google Scholar]
  220. Wood D., David T., Chrystie I., Totterdell B. Chronic enteric virus infection in two T-cell immunodeficient children. J. Med. Virol. 1988;24:435–444. doi: 10.1002/jmv.1890240410. [DOI] [PubMed] [Google Scholar]
  221. Woode G., Jones J., Bridger J. Levels of colostral antibodies against neonatal calf diarrhoea virus. Vet. Rec. 1975;97:148–149. doi: 10.1136/vr.97.8.148. [DOI] [PubMed] [Google Scholar]
  222. Woode G., Bew M., Dennis M. Studies on cross protection induced in calves by rotaviruses of calves, children and foals. Vet. Rec. 1978;103:32–34. doi: 10.1136/vr.103.2.32. [DOI] [PubMed] [Google Scholar]
  223. Woode G., Kelso N., Simpson T., Gaul S., Evans L., Babiuk L. Antigenic relationships among some bovine rotaviruses: Serum neutralization and cross-protection in gnotobiotic calves. J. Clin. Microbiol. 1983;18:358–364. doi: 10.1128/jcm.18.2.358-364.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  224. Woode G., Zheng S., Rosen B., Knight N., Gourley N., Ramig R. Protection between different serotypes of bovine rotavirus in gnotobiotic calves: Specificity of serum antibody and coproantibody responses. J. Clin. Microbiol. 1987;25:1052–1058. doi: 10.1128/jcm.25.6.1052-1058.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  225. Woode G., Zheng S., Melendy D., Ramig R. Studies on rotavirus homologous and heterologous active immunity in infant mice. Viral Immunol. 1989;2:127–132. doi: 10.1089/vim.1989.2.127. [DOI] [PubMed] [Google Scholar]
  226. Woods P., Gentsch J., Gouvea V., Mata L., Simhon A., Santosham M., Bai Z., Urasawa S., Glass R. Distribution of serotypes of human rotavirus in different populations. J. Clin. Microbiol. 1992;30:781–785. doi: 10.1128/jcm.30.4.781-785.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  227. Wright P., Tajima T., Thompson J., Kokubun K., Kapikian A., Karzon D. Candidate rotavirus vaccine (rhesus rotavirus strain) in children: An evaluation. Pediatrics. 1987;80:473–480. [PubMed] [Google Scholar]
  228. Wright P., King J., Araki K., Kondo Y., Thompson J., Tollefson S., Kogayashi M., Kapikian A. Simultaneous administration of two human-rhesus rotavirus reassortant strains of vp7 serotype 1 and 2 specificity to infants and young children. J. Infect. Dis. 1991;164:271–276. doi: 10.1093/infdis/164.2.271. [DOI] [PubMed] [Google Scholar]
  229. Wyatt R., Mebus C., Yolken R., Kalica A., James H., Kapikian A., Chanock R. Rotaviral immunity in gnotobiotic calves: heterologous resistance to human virus induced by bovine virus. Science. 1979;203:548–550. doi: 10.1126/science.216077. [DOI] [PubMed] [Google Scholar]
  230. Wyatt R., Kapikian A., Mebus C. Induction of cross-reactive serum neutralizing antibody to human rotavirus in calves after in utero administration of bovine rotavirus. J. Clin. Microbiol. 1983;18:505–508. doi: 10.1128/jcm.18.3.505-508.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  231. Yolken R., Murphy M. Sudden infant death syndrome associated with rotavirus infection. J. Med. Virol. 1982;10:291–296. doi: 10.1002/jmv.1890100409. [DOI] [PubMed] [Google Scholar]
  232. Yolken R., Wyatt R., Zissis G. Epidemiology of human rotavirus types 1 and 2 as studied by enzyme-linked immunosorbant assay. N. Engl. J. Med. 1978;299:1156–1161. doi: 10.1056/NEJM197811232992103. [DOI] [PubMed] [Google Scholar]
  233. Yolken R., Wyatt R., Mata L., Urratia J., Garcia B., Chanock R., Kapikian A. Secretory antibody directed against rotavirus in human milk—measurement by means of enzyme-linked immunosorbent assay. J. Pediatr. 1978;93:916–921. doi: 10.1016/s0022-3476(78)81211-6. [DOI] [PubMed] [Google Scholar]
  234. Zheng B., Ma G., Tam J., Lo S., Ng M., Lam B., Yeung C., Lo M. The effects of maternal antibodies on neonatal rotavirus infection. Pediatr. Infect. Dis. J. 1992;10:865–868. [PubMed] [Google Scholar]
  235. Zissis G., Lambert J., Marbehant P., Marissens D., Lobmann M., Charlier P., Delem A., Zygraich N. Protection studies in colostrum-deprived piglets of a bovine rotavirus vaccine candidate using human rotavirus strains for challenge. J. Infect. Dis. 1983;148:1061–1068. doi: 10.1093/infdis/148.6.1061. [DOI] [PubMed] [Google Scholar]

Articles from Advances in Virus Research are provided here courtesy of Elsevier

RESOURCES